drugset / Trial / NCT05125978

Efficacy and Safety of Canadá Association in the Treatment of Chronic Pain

NCT05125978

Phase 2 Withdrawn EMS
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of Canadá association in the treatment of chronic pain

Timeline

Start
2026-09
Primary completion
2028-07
Completion
2028-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Canadá Unknown Oral
Comparator Tramadol Other / unclassified Oral
Comparator dipyrone Unknown Oral

Indications